AIBN News
From tadpoles to therapeutics: Laura's journey to AIBN
Dr Laura Leighton is a postdoctoral fellow at AIBN's BASE facility, where her research focuses on making mRNA medicines safer and more precisely targeted.
Her profile traces a path from early curiosity about biology through to the practical questions that decide whether an mRNA therapy works in a patient: how the molecule is designed, how it is delivered, and which cells it reaches.
That work underpins several of the Hub's programs, where the difference between a promising construct and a usable medicine often comes down to delivery.
← Back to all news